Evidence map›Paper›PMID 23797379›Full record

ArticleJAMA internal medicine2013

Contraindicated initiation of β-blocker therapy in patients hospitalized for heart failure.

Kumar Dharmarajan, Frederick A Masoudi, John A Spertus, Shu-Xia Li, Harlan M Krumholz

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JAMA internal medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Performance measures: Unintended consequences.Nature reviews. Cardiology · 2013
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Kumar DharmarajanDivision of Cardiology, Columbia University Medical Center, New York, New York4Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut.
Frederick A Masoudi
John A Spertus
Shu-Xia Li
Harlan M Krumholz

Funding

YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
POSTDOCTORAL TRAINING IN CARDIOVASCULAR DISEASET32HL007854 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Marwah Abdalla, Michael Argenziano · 1996 to 2026
$14.7M
Center for Cardiovascular Outcomes Research at Yale UniversityU01HL105270 · NHLBI · YALE UNIVERSITY · PI CURTIS, JEPTHA PELHAM, KRUMHOLZ, HARLAN MARC · 2010 to 2013
$5.8M
NCRR NIH HHS UL1 RR024139NCRR NIH HHS UL1 RR024139-06S1NHLBI NIH HHS HL007854NHLBI NIH HHS T32 HL007854NHLBI NIH HHS U01 HL105270NHLBI NIH HHS U01 HL105270-02
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Adrenergic beta-AntagonistsHospitalizationAdministration, OralAdultAgedCardiotonic AgentsCohort StudiesContraindicationsDrug UtilizationHeart FailureHumansInfusions, IntravenousIntensive Care UnitsMyocardial InfarctionRetrospective StudiesSodium Potassium Chloride Symporter InhibitorsAdrenergic beta-AntagonistsCardiotonic AgentsSodium Potassium Chloride Symporter Inhibitors

Identifiers

PMID23797379
PMCPMC4043342

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.